4.4 Article

Changes in plasma sclerostin level associated with use of a medium cut-off dialyzer in end-stage renal disease

期刊

KIDNEY RESEARCH AND CLINICAL PRACTICE
卷 40, 期 1, 页码 120-134

出版社

KOREAN SOC NEPHROLOGY
DOI: 10.23876/j.krcp.20.173

关键词

Dialysis; Membranes; Molecular weight; Renal insufficiency

资金

  1. Korean Nephrology Research Foundation

向作者/读者索取更多资源

The study aimed to evaluate the long-term effects of MCO membrane on larger middle molecules in end-stage renal disease patients. Results showed that using MCO dialyzer significantly increased solute clearance of larger middle molecules without significant albumin loss, as well as suppressed the increase in plasma sclerostin level, compared to high-flux dialyzers.
Background: Larger middle molecules are important substances associated with cardiovascular complications in end- stage renal disease. Unfortunately, larger middle molecules are not reliably removed by a high-flux dialyzer. A medium cut-off (MCO) membrane could effectively remove larger middle molecules. This study aimed to identify the long -term effect of the MCO membrane for changes of larger middle molecules. Methods: Thirty-four patients were prospectively analyzed for 12 months. The enrolled patients were divided into control and MCO groups. We measured the plasma levels of growth differentiation factor 15, sclerostin, and fibroblast growth factor 23 in larger middle molecules and those of biomarkers including small solutes. Single-pool Kt/V (spKt/V) and reduction ratios also were evaluated. Results: Plasma sclerostin did not increase significantly in patients using the MCO dialyzer (135.3 [-637.7 to 908.3], p = 0.715). And there was a significant difference in change of plasma sclerostin level between the two groups (-1,646.9 [-3,015.2 to -278.7], p = 0.033). Furthermore, a negative association between calcium and sclerostin was not observed in the MCO group (r = -0.142, p = 0.587). Solute clearance of larger middle molecules in the MCO group was significantly higher. Moreover, spKt/V values for patients in the MCO group were significantly increased without albumin loss. Values are presented as mean (95% confidence interval [CI]) or adjusted mean (95% CI). Conclusion: The MCO dialyzer can increase dialytic adequacy and suppress the increase in plasma sclerostin level without significant albumin loss in patients with end-stage renal disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据